| ²é¿´: 821 | »Ø¸´: 7 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
dhxpyľ³æ (ÕýʽдÊÖ)
11
|
[½»Á÷]
CA on CD Êý¾Ý¿â¼ò½é¼°¼ìË÷·½·¨
|
||
|
Ò»¡¢Êý¾Ý¿â¼ò½é ÃÀ¹ú»¯Ñ§ÎÄÕªÀúÀ´ÊÇ»¯Ñ§¹¤×÷Õß¼ìË÷ÎÄÏס¢»ñÈ¡ÐÅÏ¢µÄÖ÷Òª¹¤¾ß£¬ÄÚÈÝÉæ¼°ÉúÎﻯѧ¡¢ÎÞ»ú»¯Ñ§¡¢·ÖÎö»¯Ñ§¡¢Ó¦Óû¯Ñ§¡¢»¯Ñ§¹¤³Ì¡¢´ó·Ö×Ó»¯Ñ§¡¢Óлú»¯Ñ§µÈ£¬ÊÇÊÀ½ç¹«ÈϵÄ×îÓдú±íÐÔºÍȨÍþÐԵĻ¯Ñ§ÎÄÏ×Êý¾Ý¿â¡£ËüµÄÌØµãÊÇ×ÊÁϸ²¸ÇÃæ¹ã£¬ÄÚÈÝÆëÈ«£¬ÇÒÓжàÖÖË÷Òý£¬Òò¶øÊ¹ÓÃÊ®·Ö·½±ã¡££¬Ò½Ò©ÁìÓòÊÇÆäÖеÄÖØÒª²¿·Ö£¬ÎÞÂÛÊÇ»¯ºÏÎ¸÷ÖÖÀ´Ô´µÄÔÁÏÒ©£©µÄÖÆ±¸¡¢·ÖÎö¡¢ÖƼÁ¡¢ÉúÀí»îÐÔÑо¿£¬ÄËÖÁÉ豸ÒÇÆ÷µÄÐÅÏ¢ÎÞ²»°üº¬ÆäÖС£Ëæ×Åʱ¼äµÄÍÆÒÆºÍ×ÊÁϵĻýÀÛ£¬Æ¾½èÊÖ¹¤·½·¨²éÔÄÓ¡Ë¢°æµÄ»¯Ñ§ÎÄÕª£¬¹¤×÷ЧÂÊÒѲ»ÄÜÁîÈËÂúÒâ¡£ CA on CDÓÉÃÀ¹ú»¯Ñ§Ñ§»á£¨ACS£©ÏÂÊô²¿ÃÅÃÀ¹ú»¯Ñ§ÎÄÕªÉ磨CAS£©±à¼©³ö°æ£¬ÄÚÈݶÔÓ¦ÓÚÓ¡Ë¢°æ¡¶»¯Ñ§ÎÄÕª¡·£¬Ã¿Ô¸üУ¬ÌṩÁ˸ßЧ±ã½ÝµÄ¼ìË÷;¾¶¡£ÊÕ¼ÁËÊÀ½çÉÏÔ¼8000ÖֿƼ¼ÆÚ¿¯ÒÔ¼°31¸ö¹ú¼ÒºÍµØÇøµÄרÀû£¬ÄêÎÄÏ×Á¿Ô¼70Íòƪ¡£ÆäÖÐ74%ΪÆÚ¿¯ÂÛÎÄ£¬16%ΪרÀûÎÄÏ×£¬6%Ϊ»áÒéÂÛÎÄ£¬2%ΪѧλÂÛÎÄ£¬¼¼Êõ±¨¸æºÍͼÊé¸÷Õ¼1%¡£ÆÚ¿¯ÎÄÏ×ÖÐ82.5%ΪӢÎÄÎÄÏ×£¬ÖÐÎÄÎÄÏ×Õ¼5.9%¡£×¨ÀûÎÄÏ×ÖÐ54.5%ΪÈÕ±¾×¨Àû£¬9.7%ΪÃÀ¹úרÀû£¬ÖйúרÀûÕ¼0.9%¡£ÏÖÓеÚ1013´ÎÀÛ»ýË÷Òý¼°ÎÄÕª¹âÅÌ£¬°üÀ¨ÁË19771996ÄêµÄËùÓÐÊý¾Ý£¬µÚ14´ÎÀÛ»ýË÷Òý¼°ÎÄÕª¹âÅ̽«ÓÚ2002Äê³ö°æ¡£ CA on CDµÄ³ö°æÊ¹Ñо¿ÈËÔ±²éÔÄÎÄÏ׸üΪ·½±ã£¬Ñо¿ÈËÔ±²éÎÄÏ×µÄÊÖ¶ÎÓÉ´Ë·¢ÉúÁ˸ù±¾ÐԱ仯£¬Í¬Ê±Ò²Ê¹µÃ¼ÆËã»úÇ鱨¼ìË÷ÕæÕýÃæÏòÿһ¿ÆÑÐÈËÔ±¡£CA on CD±Ø½«³ÉΪҽҩ¹¤×÷Õß»ñÈ¡ÎÄÏ×ÐÅÏ¢µÄÖ÷Òª¹¤¾ßÖ®Ò»£¬ ¶þ¡¢¼ìË÷·½·¨ 1£®CA on CDÊý¾Ý¿â½çÃæ CA on CD×îа汾µÄÈí¼þÊÇÔÚWINDOWS»·¾³ÏÂÔËÐеÄÏÂÀʽ²Ëµ¥µÄÈí¼þ£¬²Ù×÷·Ç³£¼òµ¥·½±ã£¬ÊìϤWINDOWS²Ù×÷µÄÓû§£¬Ë³×ÅÈí¼þµÄÆÁÄ»Ìáʾ£¬¼´¿É½øÐмìË÷¡£ ½øÈëÊý¾Ý¿âºó£¬ÆÁÄ»»áÏÔʾCA on CDµÄÊ×Ò³»Ã棨ÈçÉÏͼ£©¡£Çë×¢Òâ»ÃæÉϹ¤¾ßÌõÉϵÄͼ±ê£¬ÕâÀïÓÐÎå¸öͼ±ê£º Browse£¨ä¯ÀÀ£© Search£¨¼ìË÷£© Subst£¨»¯ºÏÎï¼ìË÷£© Form£¨·Ö×Óʽ¼ìË÷£© Help£¨°ïÖú£© ¿É¸ù¾Ý²»Í¬µÄ¼ìË÷ÒªÇó²ÉÓÃÏàÓ¦µÄ¼ìË÷·½Ê½£¬Ö»Ðèµã»÷¹¤¾ßÌõÉÏÏàÓ¦µÄ°´Å¥£¬°´ÕÕÆÁÄ»µÄÌáʾ¼ìË÷ÎÄÏס£¾ßÌå²Ù×÷ÈçÏ¡£ 2£®CA on CDµÄ»ù±¾²Ù×÷ CA on CD ÌṩËÄÖÖ»ù±¾¼ìË÷;¾¶£ºË÷Òýä¯ÀÀʽ¼ìË÷£¨Index Browse£© ´ÊÌõ¼ìË÷£¨Word Search£© »¯Ñ§ÎïÖÊ·Ö¼¶Ãû³Æ¼ìË÷£¨Substance Hierarchy£© ·Ö×Óʽ¼ìË÷£¨Formula£© ·Ö±ðÒÀ´Î¶ÔÓ¦ÒÔÉÏËù½éÉܵŤ¾ßÌõÉÏÒ»ÖÁËÄͼ±ê°´Å¥£¬ÒÔÏÂÒÀ´Î½éÉܸ÷;¾¶µÄ²Ù×÷·½·¨¡£ 2.1 Ë÷Òýä¯ÀÀʽ¼ìË÷£¨Browse¼ü£© Ëùνä¯ÀÀʽ¼ìË÷ÊÇÆÁÄ»´°¿Ú°´Êý×Ö×Öĸ˳ÐòÏÔʾָ¶¨µÄ¼ìË÷ÏîµÄÊõÓïÇåµ¥£¬¿ÉÓÃÀ¶¯¹ö¶¯Ìõµ½ÐèÒªµÄÊõÓï´¦£¬Ë«»÷Êó±ê»òµã»÷¡¾Search¡¿°´Å¥¡£ 2.1.1ÔÚ¼ìË÷²Ëµ¥´°¿Ú£¬ÓÃÊó±êµã»÷ ÃüÁ»òÔÚ¡°Search¡±ÃüÁî²Ëµ¥ÖÐÑ¡Ôñ¡°Index Browse¡±ÃüÁ¼´¿É½øÈëË÷Òýä¯ÀÀ¼ìË÷Ò³Ãæ¡£ ´°¿ÚÖС°Index¡±×ֶεÄȱʡֵΪWord¡£Óû§¿Éµã»÷Ë÷Òý¿òÖеÄÏÂÀʽ²Ëµ¥½øÐÐÑ¡Ôñ¡£ ¼ìË÷Ïî°üÀ¨£ºWord£¨×ÔÓÉ´Ê£¬°üÀ¨³öÏÖÔÚÎÄÏ×ÌâÄ¿¡¢ÎÄÕª¡¢¹Ø¼ü´Ê±í¡¢ÆÕͨÖ÷ÌâµÈÖÐËùÓпɼìË÷´Ê»ã£©¡¢CAS RN£¨CASµÇ¼ÇºÅ£©¡¢Author£¨×÷Õß¼°·¢Ã÷ÕßÐÕÃû£©¡¢General Subject£¨ÆÕͨÖ÷Ì⣩¡¢Patent Number£¨×¨ÀûºÅ£©¡¢Formula£¨·Ö×Óʽ£©¡¢Compound£¨»¯ºÏÎïÃû³Æ£©¡¢CAN£¨CAÎÄÕªºÅ£©¡¢Organization£¨×éÖ¯»ú¹¹¡¢ÍÅÌå×÷Õß¡¢×¨Àû¾Ö£©¡¢Journal£¨¿¯ÎïÃû³Æ£©¡¢Language£¨ÔʼÎÄÏ×µÄÓïÖÖ£©¡¢Year£¨ÎÄÕª³ö°æÄê·Ý£©¡¢Document Type£¨ÎÄÏ×ÀàÐÍ£©¡¢CA Section£¨CA·ÖÀࣩ¡¢Update£¨ÎÄÏ׸üÐÂʱ¼ä»òÊ鱾ʽ¡¶CA¡·µÄ¾í¡¢ÆÚºÅ¡££© 2.1.2 ¡°Find¡±¶Ô»°¿òÓÃÓÚÊäÈë¼ìË÷ÊõÓïµÄǰ׺£¬Ä¿µÄÊǼӿìÍÏÀʱµÄ¶¨Î»¡£ 2.1.3 µã»÷¡¾Search¡¿¼ü»ò°´¡¾Enter¡¿¼ü£¬¿ªÊ¼¼ìË÷¡£ È磺ÎÒÃÇÓû²éÓйؿ¹Ö±ä×÷ÓõÄÎÄÏ×£¬ÔÚ¡°Index¡±²Ëµ¥Ñ¡Ôñ¡°Gen.Subj¡±Ï²¢ÔÚ¡°Find¡±¿òÊäÈë¡°mutation¡±£¬ÔÙ´ÓÏÔʾµÄÇ嵥ѡÔñ¡°mutation inhibitors¡±£¬µ¥»÷¡¾Search¡¿¿É³öÏÖ¼ìË÷µÄÖмä½á¹û£¬ÈçÏÂͼ¡£¼ìË÷Õß¿ÉÔÚ´ËÅжÏÄÄЩÎÄÕÂÊÇÐèÒªµÄ¡£ ÔÚÉÏͼÖÐÎÒÃÇ¿´µ½ÓÐÐí¶àͼ±ê±»ÊÍ·Å£¬³ÉΪʵͼ±ê¡£ Print ´òÓ¡¼ìË÷Öмä½á¹û Save °Ñ¼ìË÷Öмä½á¹û´æÈëÎļþ Mark ÓÃÓÚ¶Ô¸ÐÐËȤÎÄÏ××ö±ê¼Ç£¬ÒÔ´ýÏÂÒ»²½µÄ´æ´¢ºÍ´òÓ¡ Mark All ¶ÔËùÓÐÖмä½á¹û×ö±ê¼Ç£¬ÒÔ´ýÏÂÒ»²½µÄ´æ´¢ºÍ´òÓ¡ Unmark ³·Ïû±ê¼Ç Print MK ´òÓ¡±ê¼Ç¹ýµÄÎÄÏ×È«¼Ç¼ Save MK °Ñ±ê¼Ç¹ýµÄÎÄÏ×È«¼Ç¼´¢´æÓÚÎļþÖÐ DDS MK °Ñ±ê¼Ç¹ýµÄ¼Ç¼ÒÔ±ê×¼µÄCASDDSÔÎÄË÷È¡¸ñʽ´¢´æ Clear ÇåÆÁ ÔÚÉÏͼÖеÄÎÄÏ×±êÌ⴦˫»÷Êó±ê¼´¿ÉµÃµ½Ò»ÌõCAµÄÈ«¼Ç¼£¬ÈçÏÂͼ£¬´ËʱµÄ¡°Next¡±ºÍ¡°Prev¡±°´Å¥ÓÃÓÚ·Ò³ä¯ÀÀÏÂÒ»¼Ç¼»òǰһ¼Ç¼¡£ 2.2 ´ÊÌõ¼ìË÷£¨Search¼ü) µã»÷ ÃüÁî°´Å¥£¬¿É²ÉÓò¼¶ûÂß¼×éÅ䷽ʽ½«¼ìË÷´Ê¡¢´Ê×é¡¢Êý¾Ý¡¢×¨ÀûºÅµÈÏÞ¶¨Ìõ¼þ½áºÏÆðÀ´½øÐмìË÷£¬´Ó¶øÌá¸ßÁ˼ìË÷׼ȷ³Ì¶È¡£ÕâÊÇCA on CD¼ìË÷µÄÖ÷Ҫ;¾¶£¬ÏêϸµÄ²Ù×÷¼¼ÇɿɼûʵÀý½éÉÜ¡£ 2.2.1 µã»÷¡¾Search¡¿ÃüÁî°´Å¥»òÔÚ¡°Search¡±ÃüÁî²Ëµ¥ÖÐÑ¡Ôñ¡°Word Search¡±ÃüÁ³öÏÖÈçϽçÃæ£º 2.2.2 ÔÚÆÁÄ»Öв¿µÄ¼ìË÷´ÊÊäÈë·½¿òÖÐÊäÈë¼ìË÷´Ê£¨´Ê¼ä¿ÉÓÃÂß¼×éÅ䣩¡£ 2.2.3 ÔÚÓÒ±ß×Ö¶ÎÉ趨·½¿òÖÐÑ¡¶¨ÏàÓ¦¼ìË÷´ÊµÄ×ֶΡ£È±Ê¡ÖµÎª¡°Word¡±£¬×ó±ßÑ¡Ïî·½¿òÖÐÑ¡Ôñ´Ê¼äµÄ¹ØÏµ×éÅä·û¡£´Ë´¦È±Ê¡Öµ¡°AND¡± ¡£ 2.2.4ÔÚÏÂͼ¿òÖÐÉ趨¸÷¼ìË÷´ÊÔÚÎÄÏ׼ǼÖеÄλÖùØÏµ£¨Í¬Ò»ÎÄÏ×£¬Í¬Ò»×ֶλò¼ä¸ôµ¥´ÊÊýµÈ£©¡£ 2.2.5ÓÃÊó±êµã»÷¡¾Search¡¿¼ü£¬¿ªÊ¼¼ìË÷¡£¼ìË÷Íê±Ïºó£¬ÆÁÄ»³öÏÖ¼ìË÷½á¹û£¬ÏÔʾ¼ìË÷µ½µÄÎÄÏ×ÌâÄ¿¡£¶Ô¼ìË÷´ÊµÄÊäÈ룬ϵͳÔÊÐíʹÓôú×Ö·û¡°£¿¡±¼°Í¨Åä·û¡°*¡±¡£Ã¿Ò»¸ö¡°£¿¡±´ú±íÒ»¸ö×Ö·û£¬È磺¡°Base?¡±´ú±í¼ìË÷´Ê¿ÉΪ¡°Bases¡±»ò¡°Based¡±µÈ, ¡°*¡±·ûºÅ±íʾµ¥´Êǰ·½Ò»Ö¡£ÁíÍ⣬»¹¿ÉÒÔÊäÈë¡°OR¡±×éÅä·ûÁ¬½Ó¶ø³ÉµÄ¼òµ¥¼ìË÷ʽ£¬È磺Strength or toughness¡£ 2.3 »¯Ñ§ÎïÖÊ·Ö¼¶Ãû³Æ¼ìË÷£¨Subst¼ü£© CA on CDµÄ»¯Ñ§ÎïÖÊ·Ö¼¶Ãû³ÆË÷ÒýÓëÓ¡Ë¢°æµÄ»¯Ñ§ÎïÖÊË÷Òý»ù±¾Ïàͬ£¬Êǰ´»¯Ñ§ÎïÖʵÄĸÌåÃû³Æ½øÐмìË÷µÄ£¬Óи÷ÖÖ¸±±êÌâ¼°È¡´ú»ù¡£ÓÉÓÚÓ¡Ë¢°æCAʱ¼ä¿ç¶È½Ï³¤£¬ÔÚ»¯ºÏÎïµÄÃüÃû·½Ãæ³öÏÖÁËǰºó²»Ò»ÖµÄÇé¿ö£¬¸ø¼ìË÷´øÀ´Ò»Ð©À§ÄÑ¡£¶øCA on CDÔò¿Ë·þÁËÕâ¸öȱµã£¬ÔÚÀú¾íÀÛ»ýË÷ÒýµÄ»¯Ñ§ÎïÖÊÃû³Æ±£³ÖÁËͳһ¡£ 2.3.1ÔÚ¼ìË÷´°¿ÚÖУ¬ÓÃÊó±êµã»÷ °´¼ü»ò´Ó¡°Search¡±ÃüÁî²Ëµ¥ÖÐÑ¡Ôñ¡°Substance Hierachy¡±ÃüÁϵͳ¼´½øÈ뻯ѧÎïÖÊ·Ö¼¶Ãû³Æ¼ìË÷´°¿Ú: ÆÁÄ»ÏÔʾÎïÖʵÚÒ»²ã´ÎÃû¼´Ä¸Ì廯ºÏÎïÃû³ÆË÷ÒýÕýÎÄ¡£ÎÞϲãµÈ¼¶ÃûµÄ»¯ºÏÎïÌõÄ¿ÖÐÖ±½Ó¸ø³öCAµÇ¼ºÅ£»ÓÐϲãÃû³ÆµÄÎïÖÊǰÔò³öÏÖ¡°£«¡±·ûºÅ¡£ 2.3.2 Ë«»÷Ñ¡ÖÐË÷Òý£¬½«·Ö¼¶Ë÷Òý±íÒ»²ã²ã´ò¿ª£¬ÔÙÓÃÊó±êË«»÷¸ÃÎïÖÊÌõÄ¿¼´¿É½øÐмìË÷¡£¼ìË÷Íê±Ïºó£¬ÆÁÄ»¸ø³öÆäÏà¹ØÎÄÏ×¼ìË÷½á¹û¡£ 2.4 ·Ö×Óʽ¼ìË÷£¨Form¼ü£© ·Ö×ÓʽË÷ÒýÓÉA£Z˳ÐòÅÅÁУ¬¼ìË÷¹ý³ÌÓ뻯ºÏÎï·Ö¼¶Ãû³Æ¼ìË÷ÏàËÆ¡£ 2.5 ÆäËü¹¦ÄÜ ÊéÇ©¹¦ÄÜ£¬ÊÇÓÃÓڰѼìË÷µ½ÈÏΪÓмÛÖµµÄÎÄÏ××ö±ê¼Ç£¬ÒÔ±¸½ñºóÐèҪʱµ÷Óã¬Ö»Òªµ¥»÷²Ëµ¥ÌõµÄ¡°bookmark¡±£¬ÔÙµ¥»÷¡°ADD¡¡±£¬¼´¿É°Ñ¸ÐÐËȤµÄÎÄÏ×ÓÃÕâÒ»ÎÄÏ×±êÌâ×÷ΪÏîÄ¿Ãû´¢´æÆðÀ´¡£½ñºóÈç¹ûÒª¿´ÒÔǰÒѾ¼ìË÷µ½µÄÌØ±ðÓÐÒâÒåµÄÎÄÏ×£¬¾Í¿ÉÒÔͨ¹ý¡°bookmark¡±Ö±½Óµ÷Ó㬶ø²»±Ø½øÐÐÖØ¸´µÄ¼ìË÷¹ý³Ì 3£®¼ìË÷½á¹ûÏÔʾ 3.1 ¿É¶Ô¸ÐÐËȤµÄÎÄÏ×Óá¾Mark¡¿¼ü½øÐбê×¢£¬»òÓá¾Unmark¡¿¼üÈ¡Ïû±ê×¢¡£ 3.2 µ¥»÷¡¾SaveMk¡¿¼ü´æ´¢Ëù±ê×¢µÄ¼ìË÷½á¹û£¬µ¥»÷¡¾Save¡¿¼ü´æ´¢µ±Ç°ÆÁÄ»ÏÔʾÄÚÈÝ¡£ 3.3 µ¥»÷¡¾PrintMk¡¿¿ÉÑ¡´òÓ¡¸ñʽÀ´Êä³ö¼ìË÷½á¹û£¬µ¥»÷¡¾Print¡¿¼ü´òÓ¡µ±Ç°ÆÁÄ»ÏÔʾÄÚÈÝ¡£ 3.4 Ë«»÷Ñ¡ÖеÄÎÄÏ×ÌâÄ¿£¬¿ÉµÃµ½È«¼Ç¼ÄÚÈÝ¡£ µ±¼ìË÷³öÎÄÏ×µÄÈ«¼Ç¼ʱ£¬Ò»Ð©Ð¡Í¼±ê±»¼¤»î£¬ËüÃǵÄ×÷ÓÃÈçÏÂËùÊö£º Goto µ±¹â±êÔÚijCASºÅ´¦µ¥»÷¡°Goto¡±¿ÉÒÔ¿´ÕâÒ»CASºÅµÄÏà¹Ø»¯ºÏÎïµÄÎïÖÊÐÅÏ¢¡£ NextLink ÔÚ¼ì³öµÄÎÄÏ×ÖпìËÙ¶¨Î»µ½CASºÅ´¦¡£ SrchSel °Ñ¼ìË÷½á¹ûÖÐÑ¡ÔñµÄWordÏ±êÌâ¡¢ÎÄÕª¡¢¹Ø¼ü´Ê£©µÄij´Ê×÷½øÒ»²½Á¬½Ó¼ìË÷¡£ DDS °ÑÕâÒ»¼Ç¼×ö³ÉCASDDS¸ñʽ£¬ÒÔË÷È¡ÔʼÎÄÏס£ ÕâЩ±»¼¤»îµÄͼ±êÖУ¬×îÓÐÒâÒåµÄÊÇ¡¾SrchSel¡¿£¬ËüÊÇ¡°Search Selection¡±µÄËõд¡£Èç¹û´ÓÕâÒ»½á¹ûÖп´µ½Ä³Ò»´ÊÓÐÀ©¼ìÒâÒ壬°Ñ¹â±ê¶¨ÔÚÕâÒ»´ÊµÄÇ°Ãæ£¬Í϶¯Êó±ê°ÑÕâÒ»´Ê¼ÓÇ¿£¬ÔÙµ¥»÷¡¾SrchSel¡¿£¬¼´¿É°ÑËùÓаüº¬ÓÐÕâÒ»´ÊµÄÎÄÏ×Ö±½Ó¼ì³ö¡£ 4. CA on CD ¼ìË÷ʵÀý Ç°ÃæÎÒÃÇÒѾ´óÖ½éÉÜÁËCA on CD²úÆ·µÄ½çÃæºÍ²Ù×÷·½·¨£¬ÒÔϾͼ¸¸ö¾ßÌåʵÀýÀ´½øÒ»²½½éÉÜCA on CDµÄʹÓü¼ÇÉ¡£Ê¹ÓùýÓ¡Ë¢±¾µÄCA¶ÁÕß¶¼ÖªµÀ£¬¶ÔÓÚÓ¡Ë¢±¾µÄ²éѯ£¬¼ìË÷·½·¨Ö÷ÒªÒÀ¿¿CAÌṩµÄË÷Òý£¬¸ù¾Ý²»Í¬µÄÇé¿ö¿ÉÑ¡ÔñÊʵ±µÄË÷Òý½øÐмìË÷¡£¶ø¼ìË÷µÄ;¾¶Ö÷Òª·ÖΪÒÔϼ¸ÖÖ£º a) Ö÷ÌâË÷Òý£ºÖ÷ÌâË÷ÒýÊǼìË÷Ó¡Ë¢±¾CAµÄ×îÖØÒª¡¢×î³£ÓõÄË÷Òý£¬°üÀ¨¹Ø¼ü´ÊË÷Òý¡¢»¯Ñ§ÎïÖÊË÷Òý¡¢ÆÕͨÖ÷ÌâË÷ÒýÈýÖÖ£¬Í¨¹ý²éѯµÃµ½ËùÐè×ÊÁϵÄÎÄÕªºÅ¼´¿ÉÖ±½Ó²éÔÄÎÄÕª¡£ b) ×÷Õß¼°ÐòºÅË÷Òý£º°üÀ¨×÷ÕßË÷Òý¡¢×¨ÀûË÷Òý¡¢µÇ¼ÇºÅË÷Òý£¬Õ⼸ÖÖË÷Òý±àÅŽϼòµ¥£¬¼ìË÷Ò²±ÈÓÃÖ÷ÌâË÷Òý·½±ã£¬µ«±ØÐëÁ˽â×÷ÕßÐÕÃû¡¢×¨ÀûºÅ»òÕßCAµÇ¼ÇºÅ£¬Òò´Ë¸ÃÖÖ;¾¶¾ÍÓÐÆä¾ÖÏÞÐÔ¡£ c) ·Ö×Óʽ¼°»·ÏµË÷Òý£ºÔÚÒÑÖª·Ö×ÓʽµÄÇé¿öÏ£¬¿ÉÀûÓ÷Ö×ÓʽË÷Òý»ò»·ÏµË÷Òý²é³ö¸Ã»¯Ñ§ÎïÖʵÄÃû³Æ£¬ÔÙת²é»¯Ñ§ÎïÖÊË÷Òý£¬¸Ã·¨ÔÚ¼ìË÷¾ßÓи´Ôӽṹ»¯ºÏÎïµÄʱºò½ÏΪÊÊÓᣠ×÷ΪCA on CD£¬Ëü±ü³ÐÁËÓ¡Ë¢°æCAµÄË÷ÒýÌåϵ£¬²¢ÔÚÔÓеÄÌåϵ»ù´¡ÉÏÔöÌíÁËÆäËûһЩË÷ÒýÌØÕ÷È磺¡°journal¡±¡¢¡°language¡±ÒÔ¼°¡°Doc type¡±µÈµÈ£¬Ê¹Õû¸öË÷ÒýÌåϵ¸ü¼ÓÍêÉÆ£¬¼ìË÷ÎÄÏ׸ü¼Ó¾«È·¡£Í¬Ê±CA on CDÒ²¼æ±¸Á˵çÄÔÁª»ú¼ìË÷µÄÓŵ㣬²¢²ÉÓÃWINDOWS»·¾³ÏµIJ˵¥Ê½½çÃæ£¬²Ù×÷·Ç³£·½±ã¡£Òò´ËÎÞÂÛÊǶÔÓÚÊìϤӡˢ°æCAµÄ»¯Ñ§»¯¹¤Ñо¿ÈËÔ±»¹ÊdzõѧÕß»òÊÇÆäËûÐÐÒµÈËÔ±¾ùÄÜÇáÒ×ÉÏÊÖ£¬Æä¼ìË÷µÄ¸ßЧÐÔ¡¢ÒײÙ×÷ÐÔÒÔ¼°×ÊÁϵÄÈ«ÃæÐԺ;«È·ÐÔȷʵÊÇÏÔ¶øÒ×¼ûµÄ¡£ ΪÁËÈöÁÕßÄÜÉîÈëÌå»áCA on CDµÄʹÓü¼ÇÉ£¬ÒÔϵÄʵÀý¾ù²ÉÓÃÁËÓ¡Ë¢°æCAºÍCA on CDÁ½ÖÖ¼ìË÷¹¤¾ß£¬Í¨¹ý±Ë´ËÖ®¼äµÄ¶Ô±È£¬Ê¹¶ÁÕßÄܹ»ÇáËÉÉÏÊÖ¡£ ʵÀýÒ»£ºÌ컨·Ûµ°°×ÓÃÓÚÖÎÁư¬×̲¡µÄ×îÔçרÀûÎÄÏ× a£©Ó¡Ë¢°æCAµÄ²éѯ·½·¨£ºÌ컨·Ûµ°°×£¬Ó¢ÎÄÃûTrichosanthin¡£ÓÉÓÚµ°°×ÖÊÊôÓÚ´ó·Ö×Ó£¬Ö»ÄÜͨ¹ýÆÕͨÖ÷ÌâË÷Òý¼ìË÷£¬¶øÔÚÓ¡Ë¢°æÖÐÖ±½ÓÒÔ¸ÃÎïÖʵÄÃû³Æ×÷ΪÖ÷Ìâ´Ê¼ìË÷ÊÇÎÞ·¨¼ì²âµ½ÎÄÏ׵ģ¬ÒòΪÔÚÓ¡Ë¢°æÖУ¬ËùÓеĵ°°×ÖʾùÔÚÆÕͨÖ÷ÌâË÷ÒýÖеġ°Proteins¡±Ï¼ìË÷¡£¿ÉÊÇÕâÒ»Ö÷ÌâÏÂÍøÂÞÁË´óÁ¿µÄÎÄÏ×£¬ÔÚµÚ11´ÎÀÛ»ýË÷ÒýÖС°Proteins¡±ÏÂûÓÐÏÞ¶¨´Ê£¬ÐèÒªÖðÌõ²éѯ£¬¾²éÕÒδ·¢ÏÖ·ûºÏÌõ¼þµÄ¼Ç¼¡£µ½µÚ12´ÎÀÛ»ýË÷Òýʱ£¬ÓÉÓÚµ°°×ÖÊÆ·ÖÖÌ«¶à£¬ÐÂÔöÁË¡°specific and class¡±µÄÏÞ¶¨´Ê£¬´Ó¡°Index Guide¡±µÃÖª£¬Ì컨·Ûµ°°×µÄ¼ìË÷ÏßË÷Ϊ£º Protein, specific and class Trichosanthin È»ºóÔÚµÚ12´ÎÀÛ»ýË÷ÒýµÄÆÕͨÖ÷ÌâË÷ÒýÖÐÕÒµ½Trichosanthin£¬ÆäÖйØÓÚÖÎÁư¬×̲¡µÄÎÄÏ׿ÉÖðÌõѰÕÒ£¬»ñµÃÎÄÏ×3ƪ£º human immunodeficiency virus infection treatment with, 111: P209144e human immunodeficiency virus inhibition treatment by, 111: 230s injection cong., for AIDS and cancer and hepatitis, 113: P120815b ¾Ý´Ë·ÖÎö£¬µÚһƪÉêÇëµÄרÀûÓ¦¸ÃÊÇ111: P209144e£¬ÎÄÏ×µÄÌâÄ¿ÊÇ£º Methods of selectively inhibiting human immunodeficiency virus with ribosome-inactivating protein ÓɼÓÖÝ´óѧBerkeley·ÖУµÄLifen£¬JeffreyÓëÏã¸ÛµÄYeung½ÌÊÚÒ»ÆðÉêÇëµÄרÀû£¬×¨ÀûºÅΪPCT Int. Appl. WO 88/09,123¡£ÈôÏëµÃÖªÆäרÀû±£»¤ºÍµÈͬרÀûÇé¿ö£¬Ôò¿É¸ù¾Ý´ËרÀûºÅ²éÔÄͬһÆÚµÄרÀûË÷Òý¡£ b£©CA on CDµÄ²éѯ·½·¨£º²ÉÓÃCA on CD²éѯÔò²»ÐèÒªÉÏÊöÈç´Ë·±Ëö·Ñʱ¡£ÎÒÃÇÖ»ÐèÒªÔÚ¡°Search¡±·½Ê½Ï½«ÒÑÖªµÄÌ컨·Ûµ°°×µÄÃû³ÆTrichosanthinºÍAIDSÁ½¸ö¹Ø¼ü´Ê²ÉÓò¼¶ûÂß¼AND¹ØÏµµÄ¼ìË÷;¾¶¼´¿É£¨¼ûÏÂͼ£©¡£ ÔÚµÚ11´ÎÀÛ»ýË÷ÒýµÄ¹âÅÌÊý¾Ý¿âÖÐûÓÐÕÒµ½ºÏÊʵļǼ£¬Çл»ÖÁµÚ12´ÎÀÛ»ýË÷ÒýÊý¾Ý¿âºóÒÀÈ»²ÉÓÃÏàͬµÄ¼ìË÷Ìõ¼þ£¬Ë³Àû¼ìË÷³öÈýƪ·ûºÏÌõ¼þµÄÎÄÏ×£¨¼ûÏÂͼ£©¡£ ÖðƪÔĶÁ·¢ÏÖÎÄÕªºÅΪ111:209144µÄרÀûÎÄÕªÕýÊÇËùÐèҪѰÕÒµÄÎÄÏ×£¬ÕâÓëÓ¡Ë¢°æCA¼ìË÷³öµÄ½á¹ûÒ»Ö£¨¼ûÏÂͼ£©¡£ ÈôÏëµÃÖªÆäרÀû±£»¤ºÍµÈͬרÀûÇé¿ö£¬Ôò¿ÉÔÚ¡°Search¡±»ò¡°Browse¡±·½Ê½Ï½«Ëù¼ìË÷µ½µÄרÀûºÅ²ÉÓÃרÀûºÅÏîÄ¿£¨patent£©¼ìË÷£¬¾Í¿É»ñµÃͬһÆÚ¼ä¸ÃרÀûµÄרÀû±£»¤ºÍµÈͬרÀûÇé¿ö£¨¼ûÏÂͼ£©¡£ ±¾ÌâĿҲ¿ÉÒÔ²ÉÓÃÆÕͨÖ÷ÌâÏîÄ¿£¨Gen. Subj.£©¼ìË÷£¬µ«Í¨¹ý´Ó¡°Index Guide¡±µÃÖªµÄÏßË÷¼ìË÷½ÏΪÂé·³£¬ÎÞ·¨×¼È·¶øÑ¸ËٵػñµÃ¼ìË÷½á¹û¡£ÔÚ¼ìË÷´ËÀà¾ßÓÐÃ÷ÏÔÖ÷Ìâ´ÊµÄÎÄÏ×ʱ£¬¾¡Á¿²ÉÓõ¥Ôª´ÊÏîÄ¿£¨word£©µÄ²¼¶ûÂß¼¼ìË÷£¬µ«Í¬Ê±Ó¦µ±×¢Òâµ¥´ÊµÄËõд£¬ÈçÔÚ¼ìË÷»¯Ñ§Ò©ÎïµÄÒ©ÀíѧÎÄÏ×ʱ£¬¡°pharmacology¡±ºÍÆäËõд¡°pharmacol.¡±¾ùÓ¦µ±ÒÔ²¼¶ûÂß¼»ò£¨or£©ÔËËãµÄÐÎʽ³öÏÖÔÚ¡°Search¡±·½Ê½µÄ¼ìË÷ÏîÄ¿À¸ÄÚ¡£ ʵÀý¶þ£º´ß»¯Çâ»¯ÖÆ±¸Ò½Ò©ÖмäÌå¼äÈý·ú¼×»ù±½°·µÄ¹¤ÒÕ·½·¨ a£©Ó¡Ë¢°æCAµÄ²éѯ·½·¨£º±¾Àý×ÓÉæ¼°µ½²éѯ¾ßÌ廯ºÏÎïµÄÓйØÎÄÏ×£¬ÓÉÓÚ±¾ÌâÄ¿»¯ºÏÎïÃüÃû²ÉÓõÄÊÇË×Ãû£¬ÔÚ²»ÖªµÀ¼äÈý·ú¼×»ù±½°·ÔÚCAÖеÄÃüÃûµÄÇé¿öÏ£¬Ö»µÃ´Ó·Ö×ÓʽË÷Òý×ÅÊÖ¡£Æä·Ö×ÓʽΪC7H6F3N£¬²éµÃ½á¹ûÈçÏ£º Benzenamine, ar-(trifluoromethyl)- ¡¡ ¡ª, 3-(trifluoromethyl)- [98-16-8] See Chemical Substance Index ÒÔBenzenamineΪĸÌ壬²éµÚ11´ÎÀÛ»ýË÷ÒýµÄ»¯Ñ§ÎïÖÊË÷Òý£¬ÔÚBenzenamineÀ¸ÏÂÕÒµ½ÒÔ¡ª,3-(trifluoromethyl)- [98-16-8]Ϊ¸±±êÌâµÄÎÄÕªÖ÷Ì⣬ȻºóѰÕÒµ½prepn.ÌõĿϵļǼ£º prepn. of by flourination and redn. of nitrobenzotrichloride, 105: P226004c by hydrogenation of nitro compd., catalysts for, 102: 166379e ¾·ÖÎö±È½Ï£¬·¢ÏÖÎÄÕªºÅΪ102: 166379e·ûºÏ¿ÎÌâÒªÇó¡£ b£©CA on CDµÄ²éѯ·½·¨£º½øÈëµÚ11¾íÀÛ»ýË÷ÒýµÄ¹âÅÌÊý¾Ý¿â£¬ÔÚ¡°Form¡±µÄ·½Ê½Ï£¬½«·Ö×ÓʽC7H6F3NÊäÈë¼ìË÷À¸£¬µÃµ½ÒÔËĸö»¯ºÏÎï×÷ΪĸÌåµÄ¼ìË÷½á¹û£¨¼ûÏÂͼ£©£¬ Ñ¡ÔñBenzenamineΪĸÌ壬ÔÚBenzenamine£¨SUBSTITUTED£©Ä¿Â¼ÏÂÕÒµ½¡ª,3-(trifluoromethyl)- [98-16-8]£¬´Ó¶ø»ñµÃÄ¿±ê»¯ºÏÎïµÄÃüÃûÐÅÏ¢¼°CAµÇ¼ÇºÅ£¨¼ûÏÂͼ£©¡£ ¶ø´ËʱÈô°´Ï¡¾Document¡¿¼üÔò½«»áÏÔʾ³öËùÓÐ¸ÃÆÚË÷ÒýÖÐËùÓÐÓë¸Ã»¯ºÏÎïÓйصÄÎÄÕª£¬Õâ¸öÀý×ÓÖÐÎÒÃǼìË÷µ½Óë¼äÈý·ú¼×»ù±½°·ÓйصÄÎÄÕªÓÐ161ƪ¡£ÈôÖðÆª²é¿´ÏÔȻûÓбØÒª£¬´ËʱֻÐèÔÚ¡°Search¡±µÄ·½Ê½Ï£¬½«Ëù»ñµÃ»¯ºÏÎïµÄCAµÇ¼ºÅ[98-16-8]ºÍhydrogenation£¨Ç⻯£©ÒÔ¼°preparation£¨prepn.£©½øÐв¼¶ûÂß¼¼ìË÷£¬µÃµ½9ƪÃüÖмǼ£¨¼ûÏÂͼ£©£º ·ÖÎöºóµÃµ½ÎÄÕªºÅΪ102: 166379ÎÄÏ×·ûºÏÌõ¼þ£¬ÕâÊÇÓÉǰËÕÁªµÄSavchenko, V. I.ºÍDorokhov, V. G.Á½ÈËËù·¢±íµÄ¹¤×÷£¬ÎÄÕÂÌâÄ¿¾·ÒëÈçÏ£º Catalysts and new technology for production of aromatic amines by hydrogenation of nitro compounds under normal hydrogen pressure. ±¾ÌâĿҲ¿É²ÉÓá°Sudst¡±µÄ·½Ê½¼ìË÷£¬µ«Ç°ÌáÊDZØÐëÕýÈ··ÖÎö»¯ºÏÎïµÄĸÌ壬´Ó¶ø»ñµÃ¸Ã»¯ºÏÎï¾ßÌåµÄ¼ìË÷ÐÅÏ¢£¬ÔÙͬÒÔÉϲÙ×÷£¬ÔÚ¡°Search¡±·½Ê½Ï»ñµÃËùÐèµÄÎÄÕª¼Ç¼¡£ ʵÀýÈý£ºMerck¹«Ë¾ÔÚ·¨ÄªÌæ¶¡Ò©ÎïÑо¿·½ÃæµÄÎÄÏ× a£©Ó¡Ë¢°æCAµÄ²éѯ·½·¨£º¶ÔÓÚÕâ·½Ãæ¿ÎÌâµÄ²éѯ£¬Ó¡Ë¢°æCAÌṩµÄ¼ìË÷·½·¨¾ÍÓÐЩÀ§ÄÑ¡£´Ó¿ÎÌâµÄÒªÇó¿´£¬´Ë¿ÎÌâ¿Éͨ¹ýÁ½ÖÖ·½·¨À´»ñµÃÓйØ×ÊÁÏ£¬µÚÒ»ÖÖ´Ó¹«Ë¾×ÅÊÖ²é×÷ÕßË÷Òý£¬µÚ¶þÖÖ·½·¨´ÓÎïÖÊÃû×ÅÊֲ黯ѧÎïÖÊË÷Òý¡£Merck¹«Ë¾µÄÃû³ÆÎªMerck and Co., Inc.£¬ÎïÖÊÃûΪFamotidine¡£Èç¹û²ÉÓõÚÒ»ÖÖ·½·¨²é×÷ÕßË÷Òý£¬·¢ÏÖÔÚ13´ÎÀÛ»ýË÷ÒýÖвéMerck and Co., Inc.£¬½á¹û·¢ÏÖÓÐÉÏǧÌõ¼Ç¼¡£ÒòΪMerck¹«Ë¾ÊÇÒ»¸ö¿ç¹ú´ó¹«Ë¾£¬Ã¿Äê¶¼ÓкܶàÑо¿³É¹û·¢±í£¬Èç¹ûÖðÌõѰÕÒËù»¨µÄ¾«Á¦ºÍʱ¼ä¾ù½Ï¶à£¬²»ºÏÊÊʹÓá£Ö»ÓвÉÓû¯Ñ§ÎïÖÊË÷Òý²éѯÁË£¬¾¹ý½á¹¹µÄ·ÖÎö»ñµÃ·Ö×ÓʽΪC8H15N7O2S3£¬Í¨¹ý·Ö×ÓʽË÷ÒýÖªµÀÆä»¯Ñ§Ãû³ÆÎªPropanimidamide,3-[[[2-[(aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(ami-osulfonyl)- [76824-35-6]£¬È»ºó²é»¯Ñ§ÎïÖÊË÷Òý£¬ÕÒµ½Óйط¨ÄªÌæ¶¡µÄÎÄÕª£¬¿ÉÊÇÓÉÓÚ¶Ô¸ÃÒ©ÎïµÄÑо¿³É¹û½Ï¶à£¬¶øÇÒÔÚ»¯Ñ§ÎïÖÊË÷ÒýÖеļǼ²»°üº¬×÷ÕßÐÅÏ¢£¬Õâ¾Í¸ø²éѯ´øÀ´ÁËÀ§ÄÑ£¬Ö»ÄÜÖðÆª²éÕÒ·ÖÎö£¬Ò²ÐèÒª»¨µô´óÁ¿Ê±¼äºÍ¾«Á¦¡£ b£©CA on CDµÄ²éѯ·½·¨£º²ÉÓùâÅÌÊý¾Ý¿â¾Í¼òµ¥¶àÁË£¬Ö»ÐèÔÚ¡°Search¡±µÄ·½Ê½Ï£¬Ñ¡Ôñä¯ÀÀÏîĿΪ¡°Organization¡±£¬¼ìË÷×Ö¶ÎΪMerck and Co., Inc.£¬Óëµ¥Ôª´ÊFamotidine½øÐв¼¶ûÂß¼¼ìË÷£¬¼´¿ÉµÃµ½¼ìË÷½á¹û£¨¼ûÏÂͼ£©¡£ ͼ3£8 ʵÀýËÄ£º ijÈËרÃÅ´ÓÊÂÓйØÐÄÂʲ»Æë£¨cardiac arrest£©µÄÒ©ÎïÖÎÁÆÑо¿£¬ËûÒѾ²éÔÄÁËCA2000Äê9ÔÂÒÔǰµÄÎÄÕ£¬ÏÖÔÚ2000ÄêÈ«²¿CAÒѾÊÕµ½£¬ÒªÇó²¹²é10-12ÔÂÖÐÓйØÕâÒ»Ö÷ÌâµÄÎÄÏס£ a£©Ó¡Ë¢°æCAµÄ²éѯ·½·¨£º²ÉÓÃÓ¡Ë¢°æCAʱ£¬ÓÉÓÚʱ¼äµÄ¹ØÏµ£¬ÓеÄʱºò¾íË÷ÒýÉÐδÊÕµ½£¬Ö»µÃʹÓÃ10-12ÔÂÆÚ¼äÿһÆÚµÄCA£¬ÓÃcardiac×÷Ϊ¹Ø¼ü´ÊÖð±¾¼ìË÷¡£Èç¹ûÓоíË÷ÒýµÄ»°£¬¾Í¿ÉÒÔͨ¹ýÆÕͨÖ÷ÌâË÷ÒýÈ¥²éÕÒ¡£¶øÔÚÆÕͨÖ÷ÌâË÷ÒýÖУ¬ÓÃcardiac arrestÊDz鲻µ½ËùÐèÎÄÏ׵ģ¬Ó¦¸ÃÀûÓÃIndex GuideµÄ¸½Â¼I½â¾öÎÊÌ⣬¾²éÕұȽϣ¬½«Heart×÷Ϊ¼ìË÷Èë¿Ú£¬disease and disorder×÷ΪÏÞ¶¨´Ê×îΪºÏÊÊ¡£Èç´Ë»¹ÐèÖðÌõ²éÕÒ£¬·ÖÎöËùÕÒµ½µÄ¼Ç¼ÊÇ·ñÊÇÔÚ10-12ÔÂÆÚ¼äËùб¨µÀµÄ¡£ b£©CA on CDµÄ²éѯ·½·¨£ºÓöµ½ÕâÖÖÇé¿ö£¬CA on CD¾ÍÊ®·ÖÈÝÒ×£¬ÀûÓüìË÷ÏîÄ¿Öеġ°Update¡±¹¦Äܼ´¿ÉÇáËÉʵÏÖ¿ÎÌâµÄÒªÇó¡£²ÉÓá°Search¡±·½Ê½£¬ÓÃÏîÄ¿¡°Update¡±¶Ô2000-10¡¢2000-11¡¢2000-12½øÐÐÌáÎÊ£¬Óëµ¥Ôª´Êcardiac arrest½øÐв¼¶ûÂß¼¼ìË÷¾ÍÄܵõ½ËùÒªµÄ½á¹û£¨¼ûÏÂͼ£©¡£ µ«Í¬Ê±±ØÐë×¢Ò⣬ÓÉÓÚCA on CD²»Í¬ÓÚSTN£¬²»Ö§³ÖÓÃÀ¨ºÅµÄÌáÎÊʽ£¬ËùÒÔ¼ìË÷ÏîµÄ´ÎÐò°²Åŷdz£ÖØÒª¡£Ò»°ãÀ´Ëµ£¬×ÜÊǰѡ°Âß¼»ò¡±ÏÈ×ö£¬ÔÙ×ö¡°Âß¼Ó롱¡£¶øÓÃcardiac arrestÌáÎÊ£¬Òâζ׿ìË÷³öµÄÎÄÏ×ÖÐÕâÁ½¸ö´Ê±ØÐëÏàÁÚ£¬²¢ÇÒcardiacÔÚarrestµÄÇ°Ãæ¡£µ¥»÷¡¾Search¡¿Ö®ºó£¬ÏÔʾ»ñµÃ27ƪÎÄÏס£ ´ÓÒÔÉÏËĸö²»Í¬µÄÀý×Ó¿ÉÒÔ¿´³ö£¬CA on CD²úÆ·ÀûÓÃÁ˼ÆËã»úÐÅÏ¢¼¼Êõ£¬Ê¹ÒÔÍùµÄÓ¡Ë¢°æCAµÄ²éѯ·½Ê½³öÏÖÁ˸ïÃüÐԵı仯£¬¼ìË÷·½Ê½µÄ¶àÑùÐÔ¡¢²éѯÎÄÏ׵ĸßЧÐÔÒÔ¼°½çÃæµÄÒײÙ×÷ÐÔʹCA on CD±Ø½«´úÌæÓ¡Ë¢°æCA³ÉΪÐÂÊÀ¼ÍÃÀ¹ú»¯Ñ§ÎÄÕªµÄÖ÷Òª¼ìË÷¹¤¾ß¡£ |
» ²ÂÄãϲ»¶
ÉϺ£µçÁ¦´óѧ²ÄÁÏ·À»¤ÓëвÄÁÏÖØµãʵÑéÊÒÕÐÊÕµ÷¼ÁÑо¿Éú£¨²ÄÁÏ¡¢»¯Ñ§¡¢µç»¯Ñ§£¬»·¾³£©
ÒѾÓÐ4È˻ظ´
²ÄÁÏѧÇóµ÷¼Á
ÒѾÓÐ6È˻ظ´
303Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸ÎäÀí085500»úеרҵ×Ü·Ö300Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ4È˻ظ´
281Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0805 316Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
085601Çóµ÷¼Á×Ü·Ö293Ó¢Ò»Êý¶þ
ÒѾÓÐ3È˻ظ´
08¹¤Ñ§µ÷¼Á
ÒѾÓÐ17È˻ظ´
340Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

1
2Â¥2005-05-14 03:13:44
1
|
3Â¥2005-05-14 17:52:27
xiaoyuer1984
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 488.7
- Ìû×Ó: 321
- ÔÚÏß: 30·ÖÖÓ
- ³æºÅ: 256585
- ×¢²á: 2006-06-03
- רҵ: Ò©ÎïÖÆ¼Á

4Â¥2006-07-18 12:19:49
0.5
![]() ![]() |
5Â¥2006-07-24 10:41:45
wlz581
Ìú³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 116.1
- Ìû×Ó: 74
- ÔÚÏß: 7.8Сʱ
- ³æºÅ: 91919
- ×¢²á: 2005-09-07
- ÐÔ±ð: MM
6Â¥2006-07-24 13:58:06
chemosynthesis
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 406.7
- Ìû×Ó: 307
- ÔÚÏß: 1.9Сʱ
- ³æºÅ: 260374
- ×¢²á: 2006-06-17
- רҵ: ´ß»¯»¯Ñ§

7Â¥2006-08-08 17:49:27
hfjk
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 2.6
- Ìû×Ó: 316
- ÔÚÏß: 54.7Сʱ
- ³æºÅ: 247346
- ×¢²á: 2006-05-01
- רҵ: ÓлúºÏ³É
8Â¥2006-08-13 12:13:43













»Ø¸´´ËÂ¥


